Seasonal malaria chemoprevention: closing the know–do gap

[1]  A. Dicko,et al.  Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study , 2020, The Lancet.

[2]  E. Ashley,et al.  Treatment and prevention of malaria in children. , 2020, The Lancet. Child & adolescent health.

[3]  A. Bicaba,et al.  Longitudinal analysis of the capacities of community health workers mobilized for seasonal malaria chemoprevention in Burkina Faso , 2020, Malaria Journal.

[4]  Danny W. Wilson,et al.  Targets of complement-fixing antibodies in protective immunity against malaria in children , 2019, Nature Communications.

[5]  T. Druetz.  Evaluation of direct and indirect effects of seasonal malaria chemoprevention in Mali , 2018, Scientific Reports.

[6]  R. Grais,et al.  Seasonal malaria chemoprevention: successes and missed opportunities , 2017, Malaria Journal.

[7]  Paul Milligan,et al.  Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial , 2016, PLoS medicine.

[8]  D. Chandramohan,et al.  Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial , 2015, Tropical medicine & international health : TM & IH.

[9]  S. Donegan,et al.  Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. , 2012, The Cochrane database of systematic reviews.

[10]  P. Peters,et al.  Safety and Toxicity of Sulfadoxine/Pyrimethamine , 2007, Drug safety.